You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 2, July 10, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Viral Infections
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Does Hepatitis C Virus Infection Increase the Risk of HIV Disease Progression?

Stephen J. Rossi, PharmD; Paul A. Volberding, MD; Teresa L. Wright, MD

JAMA. 2002;288:241-243.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Liver disease is an increasingly common cause of death in patients with human immunodeficiency virus (HIV) infection.1 Acquisition of hepatitis C virus (HCV) requires blood contact through contaminated needles or by transfusion; sexual transmission of HCV is uncommon.2-3 HIV accelerates the progression of HCV-related liver disease4; thus, exploring HCV treatment in coinfected patients with HCV/HIV is a priority. To date, experience with combination therapies using interferon plus ribavirin in coinfected patients has been limited, and there are emerging concerns about interactions between those drugs and HIV therapies, particularly the interaction between ribavirin and zidovudine and between ribavirin and didanosine.5 Recent data reveal a more rapid progression to cirrhosis in individuals with HCV/HIV coinfection who have not received protease inhibitor therapy, who have consumed excess alcohol, and who have a low CD4 cell count.6 These observations suggest that . . . [Full Text of this Article]

Author Affilations: Medical Service, Department of Veterans Affairs Medical Center, and the University of California, San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Hepatitis C and Progression of HIV Disease
Mark S. Sulkowski, Richard D. Moore, Shruti H. Mehta, Richard E. Chaisson, and David L. Thomas
JAMA. 2002;288(2):199-206.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Determinants of Survival among HIV-Infected Chronic Dialysis Patients
Rodriguez et al.
J. Am. Soc. Nephrol. 2003;14:1307-1313.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.